CURXQ Financials 07/16/2014 09:51:56 Curaxis Phar
Post# of 3
Posted On: 07/16/2014 10:51:53 AM
CURXQ Financials 07/16/2014 09:51:56
Curaxis Pharmaceutical Corp
Period Ending Dec 31, 2011 Dec 31, 2010
Total Revenue - -
Cost of Revenue - -
Gross Profit - -
Operating Expenses
Research and Development 33 78
Sales, General and Admin. 1,889 1,859
Non-Recurring Items - -
Other - -
Operating Income (1,922) (1,937)
Income From Continuing Operations
Add'l Income/Expense Items 3,519 (132)
Earnings Before Interest and Tax 1,334 (2,448)
Interest Expense - -
Earnings Before Tax 1,334 (2,448)
Income Tax - -
Minority Interest - -
Equity Earnings Unconsolidated Subsidiary - -
Net Income Cont. Operations 1,334 (2,244)
Non Recurring Events
Discontinued Operations - -
Extraordinary Items - -
Effect of Accounting Changes - -
Other Items - -
Net Income 1,334 (2,244)
Preferred Stock and Other Adjustments - -
Net Income Applicable to Common Shareholders 1,334 (2,244)
Curaxis Pharmaceutical Corp
Period Ending Dec 31, 2011 Dec 31, 2010
Total Revenue - -
Cost of Revenue - -
Gross Profit - -
Operating Expenses
Research and Development 33 78
Sales, General and Admin. 1,889 1,859
Non-Recurring Items - -
Other - -
Operating Income (1,922) (1,937)
Income From Continuing Operations
Add'l Income/Expense Items 3,519 (132)
Earnings Before Interest and Tax 1,334 (2,448)
Interest Expense - -
Earnings Before Tax 1,334 (2,448)
Income Tax - -
Minority Interest - -
Equity Earnings Unconsolidated Subsidiary - -
Net Income Cont. Operations 1,334 (2,244)
Non Recurring Events
Discontinued Operations - -
Extraordinary Items - -
Effect of Accounting Changes - -
Other Items - -
Net Income 1,334 (2,244)
Preferred Stock and Other Adjustments - -
Net Income Applicable to Common Shareholders 1,334 (2,244)
(0)
(0)Curaxis Pharmaceutical Corporation (CURXQ) Stock Research Links
Scroll down for more posts ▼